(Reuters Health) - Many patients with neurologic disorders like multiple sclerosis, epilepsy and Parkinson's disease have seen steep increases in their out-of-pocket costs for drugs in recent years, a U.S. study suggests.
from Reuters: Health https://reut.rs/2J7ECal
via IFTTT
0 comments: